Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Liquid biopsies multi-modal analysis correlates with disease burden and response to treatment in paediatric cancer

Saturday, October 14, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster presented at SIOP 2023 discusses the correlation between liquid biopsies and disease burden in pediatric cancer. The study highlights how multi-modal analysis can provide insights into treatment responses. This research could pave the way for enhanced monitoring and personalized treatment strategies for young cancer patients.
Price reaction · baseline $13.2 (2023-10-13 close) · 5 other VNRX headline(s) in the window, move may be shared
day 0 close
+0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Liquid biopsies show promise in pediatric cancer treatment.
  • Multi-modal analysis correlates well with disease burden.
  • Potential for improved treatment response monitoring.

Full Press Release Details

Poster title: “Liquid biopsies multi-modal analysis correlates with disease burden and response to treatment in paediatric cancer.”
Presented at: SIOP 2023
Angelini et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was presented at SIOP 2023?

A poster on liquid biopsies and their correlation with disease burden in pediatric cancer.

How do liquid biopsies help in pediatric cancer?

They provide insights into disease burden and treatment response.

Who conducted the research on liquid biopsies?

The research was conducted by Angelini et al.

What is the significance of multi-modal analysis?

It enhances the understanding of treatment responses in pediatric cancer.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare liquid biopsies pediatric cancer treatment response disease burden SIOP 2023
Last updated: Oct 14, 2023

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk